DR. LEONID SHUNYAKOV MD NPI 1396709895

NPI Information

  • NPI: 1396709895
  • Provider Name: DR. LEONID SHUNYAKOV, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1501 N OAKLAND AVE
    BOLIVAR, MO
    ZIP 65613
  • Phone: (417) 326-7200

Map and Directions

Get Directions

NPI Details

DR. Leonid Shunyakov, MD is a medical oncology internal medicine in Bolivar, MO with 30 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Leonid Shunyakov, MD NPI is 1396709895. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1501 N OAKLAND AVE
BOLIVAR, MO
ZIP 65613-020
Phone: (417) 326-7200
Fax: (417) 326-7201

The NPI 1396709895 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Declotting of central venous tube (HCPCS:36593)
  • Injection, lorazepam, 2 mg (HCPCS:J2060)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)

The enumeration date for this NPI number is 4/13/2006 and was last updated on 10/10/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology04-31660KANSASNo
2207RX0202XInternal MedicineMedical Oncology2005002905MISSOURIYes
3207RH0003XInternal MedicineHematology & Oncology2005002905MISSOURINo
4207RH0003XInternal MedicineHematology & Oncology04-31660KANSASNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.